Published in Cancer Res on November 01, 1994
New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids (2007) 1.17
Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness. PLoS One (2011) 0.96
Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1). Drug Metab Dispos (2014) 0.80
Bioactivation of the cancer chemopreventive agent tamoxifen to quinone methides by cytochrome P4502B6 and identification of the modified residue on the apoprotein. Drug Metab Dispos (2012) 0.76
Idoxifene is equipotent to tamoxifen in inhibiting mammary carcinogenesis but forms lower levels of hepatic DNA adducts. Br J Cancer (1997) 0.76
Potential anti-genotoxic effect of sodium butyrate to modulate induction of DNA damage by tamoxifen citrate in rat bone marrow cells. Cytotechnology (2016) 0.75
Tandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeutics. Mass Spectrom Rev (2012) 0.75
Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature (1974) 3.47
Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil. Lancet (1998) 2.06
Interaction of omeprazole with DNA in rat tissues. Mutagenesis (1992) 2.03
Strength increases from the motor program: comparison of training with maximal voluntary and imagined muscle contractions. J Neurophysiol (1992) 1.86
Correlation of DNA adduct levels in human lung with cigarette smoking. Nature (1989) 1.86
Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis (1997) 1.78
Memory representations underlying motor commands used during manipulation of common and novel objects. J Neurophysiol (1993) 1.77
Sensory-motor coordination during grasping and manipulative actions. Curr Opin Neurobiol (1992) 1.67
Formation of K-region epoxides as microsomal metabolites of pyrene and benzo(a)pyrene. Biochem Pharmacol (1972) 1.57
Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res (2001) 1.40
Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev (1995) 1.40
Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res (1999) 1.26
Epoxides as microsomal metabolites of polycyclic hydrocarbons. FEBS Lett (1971) 1.25
DNA adducts in human environmentally exposed to aromatic compounds in an industrial area of Poland. Carcinogenesis (1990) 1.24
p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis (1996) 1.21
Coordination of three-joint digit movements for rapid finger-thumb grasp. J Neurophysiol (1986) 1.19
Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res (1994) 1.16
Aromatic DNA adducts in human bone marrow and peripheral blood leukocytes. Carcinogenesis (1986) 1.14
Grasp stability during manipulative actions. Can J Physiol Pharmacol (1994) 1.14
Monitoring occupational exposure to carcinogens: detection by 32P-postlabelling of aromatic DNA adducts in white blood cells from iron foundry workers. Mutat Res (1988) 1.13
Polycyclic hydrocarbon epoxides: the involvement of 8,9-dihydro-8,9-dihydroxybenz (a) anthracene 10,11-oxide in reactions with the DNA of benz (a) anthracene-treated hamster embryo cells. FEBS Lett (1974) 1.11
Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemother Pharmacol (1998) 1.10
Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Cancer Res (2001) 1.10
Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis (2000) 1.09
Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. Carcinogenesis (1992) 1.08
Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int J Cancer (1990) 1.07
Gastrointestinal side effects with erythromycin preparations. Drug Intell Clin Pharm (1987) 1.06
Kinematic and electromyographic responses to perturbation of a rapid grasp. J Neurophysiol (1987) 1.04
In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul Toxicol Pharmacol (2004) 1.04
Comparison of the formation of 8-hydroxy-2'-deoxyguanosine and single- and double-strand breaks in DNA mediated by fenton reactions. Chem Res Toxicol (1998) 1.03
32P-postlabelling detection of aromatic DNA adducts in peripheral blood lymphocytes from aluminium production plant workers. Mutat Res (1991) 1.01
The involvement of a diol-epoxide in the metabolic activation of benzo(a)pyrene in human bronchial mucosa and in mouse skin. Int J Cancer (1976) 1.01
Postlabeling and immunoassay analysis of polycyclic aromatic hydrocarbons--adducts of deoxyribonucleic acid in white blood cells of foundry workers. Scand J Work Environ Health (1990) 1.01
Wrist kinematics differ in expert and novice tennis players performing the backhand stroke: implications for tennis elbow. J Biomech (1994) 1.00
A new head-mounted lip-jaw movement transduction system for the study of motor speech disorders. J Speech Hear Res (1983) 0.99
Covalent binding of components of coal-tar, creosote and bitumen to the DNA of the skin and lungs of mice following topical application. Carcinogenesis (1988) 0.98
Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack. Chem Res Toxicol (1997) 0.98
Isolation of dengue viruses by intracerebral inoculation of mosquito larvae. J Virol Methods (1986) 0.98
Heterocyclic aromatic amines induce DNA strand breaks and cell transformation. Carcinogenesis (1999) 0.97
Biotransformation of the platinum drug JM216 following oral administration to cancer patients. Cancer Chemother Pharmacol (1996) 0.97
Source-pathway separation of multiple contaminants during a rainfall-runoff event in an artificially drained agricultural watershed. J Environ Qual (2010) 0.96
Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis. Cancer Epidemiol Biomarkers Prev (1998) 0.96
Formation of DNA adducts in the skin of psoriasis patients, in human skin in organ culture, and in mouse skin and lung following topical application of coal-tar and juniper tar. J Invest Dermatol (1990) 0.95
Wrist action affects precision grip force. J Neurophysiol (1997) 0.94
Parkinsonian deficits in serial multiarticulate movements for speech. Brain (1989) 0.93
Lack of genotoxicity of tamoxifen in human endometrium. Cancer Res (1996) 0.93
Metabolism of polycyclic hydrocarbons by rat-lung preparations. Biochem Pharmacol (1974) 0.92
Correlative changes in metabolism and DNA damage in turbot (Scophthalmus maximus) exposed to benzo[a]pyrene. Mar Environ Res (2002) 0.92
Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy. Biochim Biophys Acta (2003) 0.92
Primary cultures of prostate cells and their ability to activate carcinogens. Prostate Cancer Prostatic Dis (2002) 0.92
The metabolic activation of 7-methylbenz(a)anthracene in mouse skin. Chem Biol Interact (1977) 0.91
Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive. Mutagenesis (2006) 0.91
Kinematic variability of grasp movements as a function of practice and movement speed. Exp Brain Res (1988) 0.90
Genotoxicity characteristics of reverse diol-epoxides of chrysene. Carcinogenesis (1993) 0.90
GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels. Eur J Cancer Prev (1999) 0.90
Formation of epoxides as microsomal metabolites of polycyclic hydrocarbons. Biochem J (1971) 0.90
Detection of bulky DNA lesions in the liver of patients with Wilson's disease and primary haemochromatosis. Mutat Res (1995) 0.90
Grip-force responses to unanticipated object loading: load direction reveals body- and gravity-referenced intrinsic task variables. Exp Brain Res (1996) 0.89
Effect of passive and active recovery on the resynthesis of muscle glycogen. Med Sci Sports Exerc (1994) 0.89
Coordination of index finger movements. J Biomech (1994) 0.89
Antibody-directed enzyme prodrug therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial. Cancer Chemother Pharmacol (1997) 0.89
Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen. Carcinogenesis (1994) 0.88
Effect of fat emulsion infusion and fat feeding on muscle glycogen utilization during cycle exercise. J Appl Physiol (1985) (1993) 0.87
Smoking and DNA damage in cervical cells. Lancet (1990) 0.87
Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer? Br J Urol (1997) 0.87
Control of multimovement coordination: sensorimotor mechanisms in speech motor programming. J Mot Behav (1984) 0.87
The preparation of dihydrodiols from 7-methylbenz[a]-anthracene. Chem Biol Interact (1978) 0.86
Analysis of tamoxifen and its metabolites by on-line capillary electrophoresis-electrospray ionization mass spectrometry employing nonaqueous media containing surfactants. Anal Chem (1996) 0.86
Prevalence, distribution and intensity of soil-transmitted helminthiases among Malaysian children. Public Health (1987) 0.85
Aromatic DNA adducts in white blood cells of coke workers. Int Arch Occup Environ Health (1990) 0.85
Effect of L-carnitine supplementation on muscle and blood carnitine content and lactate accumulation during high-intensity sprint cycling. Int J Sport Nutr (1994) 0.85
DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma. Gut (2003) 0.85
Relationship between mutagenicity and DNA adduct formation in mammalian cells for fjord- and bay-region diol-epoxides of polycyclic aromatic hydrocarbons. Chem Biol Interact (1991) 0.83
Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cells. Br J Cancer (2004) 0.83
Detection of dengue virus by immunofluorescence following inoculation of mosquito larvae. Lancet (1983) 0.83
Autogenic and nonautogenic sensorimotor actions in the control of multiarticulate hand movements. Exp Brain Res (1984) 0.83
Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling. Cancer Res (1999) 0.83
DNA adducts in human breast tissue: association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes. Cancer Epidemiol Biomarkers Prev (1998) 0.83
Formation of DNA adducts in human skin maintained in short-term organ culture and treated with coal-tar, creosote or bitumen. Int J Cancer (1988) 0.83
The formation of dihydrodiols by the chemical or enzymic oxidation of benz[a] anthracene and 7,12-dimethylbenz[a] anthracene. Chem Biol Interact (1978) 0.83
Identification of prodrug, active drug, and metabolites in an ADEPT clinical study. Cell Biophys (1995) 0.82
Induction of activating mutations in the human c-Ha-ras-1 proto-oncogene by oxygen free radicals. Mol Carcinog (1994) 0.82
Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen. Cancer Res (1996) 0.82
Metabolic proficiency and benzo[a]pyrene DNA adduct formation in APCMin mouse adenomas and uninvolved mucosa. Carcinogenesis (1999) 0.82
The inducibility and catalytic activity of cytochromes P450c (P450IA1) and P450d (P450IA2) in rat tissues. Biochem Pharmacol (1990) 0.82
Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon. Br J Cancer (2005) 0.82
K-region epoxides of polycyclic hydrocarbons: formation and further metabolism of benz (a) anthracene 5,6-oxide by human lung preparations. FEBS Lett (1973) 0.82
DNA damage in breast epithelial cells: detection by the single-cell gel (comet) assay and induction by human mammary lipid extracts. Carcinogenesis (1997) 0.82
DNA adducts in human urinary bladder and other tissues. Environ Health Perspect (1993) 0.82
Dietary methionine does not reduce penetrance in curly tail mice but causes a phenotype-specific decrease in embryonic growth. J Nutr (1995) 0.82
Physiologic loading of the anterior cruciate ligament does not activate quadriceps or hamstrings in the anesthetized cat. Am J Sports Med (1991) 0.81
The expression of xenobiotic-metabolizing enzymes in human prostate and in prostate epithelial cells (PECs) derived from primary cultures. Prostate (2006) 0.81
Enzyme-mediated phosphorylation of polycyclic hydrocarbon metabolites: detection of non-adduct compounds in the 32P-postlabelling assay. Carcinogenesis (1989) 0.81
Influence of the alkyl substituent on mutagenicity and covalent DNA binding of bay region diol-epoxides of 7-methyl- and 7-ethylbenz(a)anthracene in Salmonella and V79 Chinese hamster cells. Cancer Res (1989) 0.81
Muscle activation patterns and kinetics of human index finger movements. J Neurophysiol (1990) 0.81
DNA adduct formation in mice following treatment with used engine oil and identification of some of the major adducts by 32P-postlabelling. Cancer Lett (1992) 0.81